WORCESTER, Mass., June 26, 2009 (GLOBE NEWSWIRE) -- Antigen Express Inc., a wholly owned subsidiary of Generex Biotechnology Corporation (Nasdaq:GNBT), has developed new vaccine technology that “could rapidly lead to safe, effective flu vaccines,” according to a June 23, 2009 article in the Worcester, Massachusetts Telegram & Gazette.
